Titan Pharmaceuticals Inc (TTNP)
6.97
-0.04
(-0.57%)
USD |
NASDAQ |
Apr 24, 16:00
Titan Pharmaceuticals Total Assets (Quarterly): 8.086M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.086M |
September 30, 2023 | 9.999M |
June 30, 2023 | 0.812M |
March 31, 2023 | 2.168M |
December 31, 2022 | 4.058M |
September 30, 2022 | 6.276M |
June 30, 2022 | 8.319M |
March 31, 2022 | 10.32M |
December 31, 2021 | 7.994M |
September 30, 2021 | 9.637M |
June 30, 2021 | 11.51M |
March 31, 2021 | 13.82M |
December 31, 2020 | 8.087M |
September 30, 2020 | 8.018M |
June 30, 2020 | 9.762M |
March 31, 2020 | 13.26M |
December 31, 2019 | 9.522M |
September 30, 2019 | 5.304M |
June 30, 2019 | 6.761M |
March 31, 2019 | 11.44M |
December 31, 2018 | 14.10M |
September 30, 2018 | 11.85M |
June 30, 2018 | 4.617M |
March 31, 2018 | 5.29M |
December 31, 2017 | 8.905M |
Date | Value |
---|---|
September 30, 2017 | 12.74M |
June 30, 2017 | 9.414M |
March 31, 2017 | 13.07M |
December 31, 2016 | 18.67M |
September 30, 2016 | 23.54M |
June 30, 2016 | 25.30M |
March 31, 2016 | 12.00M |
December 31, 2015 | 13.29M |
September 30, 2015 | 14.91M |
June 30, 2015 | 17.31M |
March 31, 2015 | 18.39M |
December 31, 2014 | 20.85M |
September 30, 2014 | 13.22M |
June 30, 2014 | 14.25M |
March 31, 2014 | 16.12M |
December 31, 2013 | 18.42M |
September 30, 2013 | 15.52M |
June 30, 2013 | 16.91M |
March 31, 2013 | 23.53M |
December 31, 2012 | 24.83M |
September 30, 2012 | 10.74M |
June 30, 2012 | 10.05M |
March 31, 2012 | 7.509M |
December 31, 2011 | 10.22M |
September 30, 2011 | 6.551M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.812M
Minimum
Jun 2023
13.82M
Maximum
Mar 2021
8.090M
Average
8.087M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
Outset Medical Inc | 313.80M |
Allurion Technologies Inc | 71.71M |
AIM ImmunoTech Inc | 19.38M |
Protalix BioTherapeutics Inc | 84.43M |
Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.444M |
Shareholders Equity (Quarterly) | 6.642M |